Skip to content
HCN Grants Est. 2026
No. HT942526ORPCRA · Defense Health Agency Contracting Activity - DHACA
Open

DoW Orthopaedic, Clinical Research Award

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“Invitation to Submit an Application: September 25, 2026” — From the announcement

At a glance

The FY26 Orthopaedic Clinical Research Award funds clinical research or clinical trials on orthopaedic-specific factors and interventions, with the goal of improving patient care and reducing the burden of orthopaedic injury. Applicants must address at least one listed focus area, and the program is aimed at benefits for Service Members, their families, Veterans, and the general public. U.S. Department of War organizations and other U.S. organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities, may apply; eligible principal investigators can be at all career levels. Cost sharing is not required. The program expects about two awards at the Research Level 1 cap of $2.0 million each and about three awards at the Research Level 2 cap of $3.2 million each, with a maximum project period of 4 years. There are no geographic restrictions stated, but the notice says animal research is not allowed and that RL2 trials must begin within six months after the award date.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • General Public / Community-wide
  • Veterans, Military & Public-Safety Personnel
  • Biomedical & Disease Research
  • Defense, National Security & Aerospace
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas. Distinctive Features: · The CRA offers two research levels. Research Level 1 (RL1) supports clinical research in the following FY26 ORP focus areas: · Ligamentous Trauma · Osseointegration Outcomes · Return-to-Duty Strategies · Military Women’s Health Research Level 2 (RL2) supports clinical trials in the following FY26 ORP focus areas: · Ligamentous Trauma · Limb Stabilization and Protection · Return-to-Duty Strategies

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide